Post-COVID-19 Opsoclonus-myoclonus Syndrome and Encephalopathy Associated with Leucine-rich Glioma-inactivated 1 (LGI-1) Antibodies
Overview
Authors
Affiliations
Brandes L, Orme D, Bermeo-Ovalle A, Sierra Morales F J Neural Transm (Vienna). 2024; 131(8):961-969.
PMID: 38847905 DOI: 10.1007/s00702-024-02789-9.
De Novo Movement Disorders Associated with COVID-19- A Systematic Review of Individual Patients.
Pillai K, Misra S, Siripurapu G, Aliyar A, Bhat P, Rajan R Ann Indian Acad Neurol. 2023; 26(5):702-707.
PMID: 38022478 PMC: 10666879. DOI: 10.4103/aian.aian_572_23.
Movement Disorders and SARS-CoV-2.
Fung W, Fasano A, Fearon C Mov Disord Clin Pract. 2023; 10(Suppl 2):S9-S17.
PMID: 37637980 PMC: 10448146. DOI: 10.1002/mdc3.13615.
Adult-onset idiopathic opsoclonus-myoclonus syndrome.
Zhang X, Yan W, Song Y, Zhu H, Sun Y Arq Bras Oftalmol. 2023; .
PMID: 36995813 PMC: 11619083. DOI: 10.5935/0004-2749.2022-0024.
Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.
Finsterer J, Scorza F Neuroophthalmology. 2023; 47(1):1-6.
PMID: 36798867 PMC: 9928447. DOI: 10.1080/01658107.2022.2128378.